Crossmark Global Holdings Inc. boosted its position in shares of Oracle Corporation (NYSE:ORCL - Free Report) by 0.7% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 242,478 shares of the enterprise software provider's stock after acquiring an additional 1,701 shares during the period. Oracle comprises 0.6% of Crossmark Global Holdings Inc.'s investment portfolio, making the stock its 27th biggest holding. Crossmark Global Holdings Inc.'s holdings in Oracle were worth $33,901,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Harel Insurance Investments & Financial Services Ltd. boosted its holdings in shares of Oracle by 71.6% in the 1st quarter. Harel Insurance Investments & Financial Services Ltd. now owns 257,378 shares of the enterprise software provider's stock valued at $35,984,000 after buying an additional 107,404 shares in the last quarter. Rockland Trust Co. raised its position in Oracle by 4.8% in the 1st quarter. Rockland Trust Co. now owns 10,165 shares of the enterprise software provider's stock valued at $1,421,000 after purchasing an additional 467 shares during the last quarter. Calamos Advisors LLC boosted its stake in Oracle by 1.5% during the 1st quarter. Calamos Advisors LLC now owns 711,290 shares of the enterprise software provider's stock worth $99,445,000 after purchasing an additional 10,426 shares during the period. Cornerstone Advisory LLC boosted its stake in Oracle by 34.1% during the 4th quarter. Cornerstone Advisory LLC now owns 12,968 shares of the enterprise software provider's stock worth $2,258,000 after purchasing an additional 3,299 shares during the period. Finally, Peak Retirement Planning Inc. acquired a new stake in Oracle during the 4th quarter worth $211,000. Institutional investors and hedge funds own 42.44% of the company's stock.
Analysts Set New Price Targets
A number of analysts recently weighed in on ORCL shares. UBS Group set a $250.00 price target on shares of Oracle and gave the stock a "buy" rating in a research note on Wednesday, June 25th. CIBC reiterated a "buy" rating on shares of Oracle in a research note on Monday, June 9th. Morgan Stanley reiterated an "overweight" rating on shares of Oracle in a research note on Wednesday, June 18th. KeyCorp increased their price target on shares of Oracle from $200.00 to $225.00 and gave the stock an "overweight" rating in a research note on Thursday, June 12th. Finally, Raymond James Financial reiterated a "strong-buy" rating on shares of Oracle in a research note on Wednesday, June 18th. Ten equities research analysts have rated the stock with a hold rating, twenty-two have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $204.15.
Check Out Our Latest Analysis on ORCL
Insider Buying and Selling at Oracle
In other Oracle news, Director Leon E. Panetta sold 17,500 shares of the firm's stock in a transaction dated Friday, May 2nd. The shares were sold at an average price of $151.24, for a total transaction of $2,646,700.00. Following the completion of the transaction, the director directly owned 58,090 shares in the company, valued at approximately $8,785,531.60. This trade represents a 23.15% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Naomi O. Seligman sold 2,866 shares of Oracle stock in a transaction dated Monday, May 5th. The stock was sold at an average price of $149.53, for a total transaction of $428,552.98. Following the sale, the director owned 31,764 shares of the company's stock, valued at approximately $4,749,670.92. This trade represents a 8.28% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 440,366 shares of company stock valued at $83,103,603. Insiders own 42.20% of the company's stock.
Oracle Price Performance
Shares of ORCL traded down $5.02 during trading hours on Monday, reaching $232.30. The company had a trading volume of 16,061,923 shares, compared to its average volume of 10,185,331. The firm has a 50 day simple moving average of $178.14 and a 200-day simple moving average of $164.22. The company has a current ratio of 0.75, a quick ratio of 0.75 and a debt-to-equity ratio of 4.07. The company has a market capitalization of $652.49 billion, a price-to-earnings ratio of 53.53, a PEG ratio of 3.55 and a beta of 1.39. Oracle Corporation has a 12-month low of $118.86 and a 12-month high of $237.99.
Oracle (NYSE:ORCL - Get Free Report) last posted its earnings results on Wednesday, June 11th. The enterprise software provider reported $1.70 earnings per share for the quarter, beating the consensus estimate of $1.64 by $0.06. Oracle had a net margin of 21.68% and a return on equity of 87.34%. The firm had revenue of $15.90 billion during the quarter, compared to the consensus estimate of $15.58 billion. During the same period last year, the firm posted $1.63 EPS. The firm's revenue for the quarter was up 11.3% on a year-over-year basis. Research analysts expect that Oracle Corporation will post 5 earnings per share for the current year.
Oracle Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Thursday, July 24th. Shareholders of record on Thursday, July 10th will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Thursday, July 10th. This represents a $2.00 annualized dividend and a yield of 0.86%. Oracle's dividend payout ratio (DPR) is currently 46.08%.
Oracle Company Profile
(
Free Report)
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
See Also

Before you consider Oracle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.
While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report